These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 27902670

  • 21. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease.
    Okomo U, Meremikwu MM.
    Cochrane Database Syst Rev; 2015 Mar 12; (3):CD005406. PubMed ID: 25764071
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A Case Report: Subanesthetic Ketamine Infusion for Treatment of Cancer-Related Pain Produces Urinary Urge Incontinence.
    Vickers BA, Lee W, Hunsberger J.
    A A Case Rep; 2017 May 01; 8(9):219-221. PubMed ID: 28118213
    [Abstract] [Full Text] [Related]

  • 25. Can gradual dose titration of ketamine for management of neuropathic pain prevent psychotomimetic effects in patients with advanced cancer?
    Okamoto Y, Tsuneto S, Tanimukai H, Matsuda Y, Ohno Y, Tsugane M, Uejima E.
    Am J Hosp Palliat Care; 2013 Aug 01; 30(5):450-4. PubMed ID: 22833552
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Opioid treatment for acute and chronic pain in patients with sickle cell disease.
    Carroll CP.
    Neurosci Lett; 2020 Jan 01; 714():134534. PubMed ID: 31593753
    [Abstract] [Full Text] [Related]

  • 30. [Pain management in sickle cell disease].
    Rasche T, Emmert D, Seidel H, Sellin J, Conrad R, Mücke M.
    Schmerz; 2020 Jun 01; 34(3):285-296. PubMed ID: 32367470
    [Abstract] [Full Text] [Related]

  • 31. Low-Dose Ketamine Infusion for Emergency Department Patients with Severe Pain.
    Ahern TL, Herring AA, Miller S, Frazee BW.
    Pain Med; 2015 Jul 01; 16(7):1402-9. PubMed ID: 25643741
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Study protocol for a randomized, blinded, controlled trial of ketamine for acute painful crisis of sickle cell disease.
    Alshahrani MS, Asonto LP, El Tahan MM, Al Sulaibikh AH, Al Faraj SZ, Al Mulhim AA, Al Abbad MF, Al Nahhash SA, Aldarweesh MN, Mahmoud AM, Almaghraby N, Al Jumaan MA, Al Junaid TO, Al Hawaj FM, AlKenany S, ElSayed OF, Abdelwahab HM, Moussa MM, Alossaimi BK, Alotaibi SK, AlMutairi TM, AlSulaiman DA, Al Shahrani SD, Alfaraj D, Alhazzani W.
    Trials; 2019 May 27; 20(1):286. PubMed ID: 31133061
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
    Ender KL, Krajewski JA, Babineau J, Tresgallo M, Schechter W, Saroyan JM, Kharbanda A.
    Pediatr Blood Cancer; 2014 Apr 27; 61(4):693-6. PubMed ID: 24249617
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Haemorheological treatment of painful sickle cell crises. Use of pentoxifylline.
    Poflee VW, Gupta OP, Jain AP, Jajoo UN.
    J Assoc Physicians India; 1991 Aug 27; 39(8):608-9. PubMed ID: 1814876
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.